Cell MedX Corp.

04/04/2024 | Press release | Distributed by Public on 04/04/2024 13:52

Private Placement - Form 8-K

ITEM 3.02DEPARTURE OF DIRECRTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.

Election of Directors

As disclosed in Cell MedX Corp.'s (the "Company") definitive Schedule 14C information statement (the "Information Statement"), filed with the Securities and Exchange Commission on or about March 6, 2024, stockholders of the Company holding 66.0% of the outstanding shares of the Company's common stock executed written consents to elect the following persons as directors of the Company, which election became effective on or about April 1, 2024:

David Jeffs

Dr. George Adams

Joao (John) Da Costa

Amir Vahabzadeh

The information required by Item 404(a) of Regulation SK was included in the Information Statement and is incorporated by reference herein.

Cell MedX Corp. published this content on April 04, 2024, and is solely responsible for the information contained herein. Distributed via SEC EDGAR on April 04, 2024 at 19:52 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at support@pubt.io